High levels of cyclin E, resulting in Rb pathway dysfunction, cytoplasmic localization of p21 and p27Kip1 loss are common occurrences and are also associated with estrogen resistance and inferior breast cancer outcomes [29,47–49]. Here, RB1 is linked to breast carcinoma.